Medications

Blue Shield of California is working with Amazon and Mark Cuban's drug company to transform the prescription drug system, which rewards stakeholders for selling higher priced drugs.

Biogen said on Tuesday it expects to eliminate roughly 1,000 positions in the U.S. to save money ahead of launching a new drug to treat Alzheimer's disease.

Alzheimer’s drug Leqembi received full approval from the U.S. Food and Drug Administration. An expert explains why this is a milestone in the treatment of the progressive disease.

TikTok users have been testing out berberine, which is an herbal supplement, that is gaining popularity for its alleged weight loss effects.

AI-driven technology developed by VeriSIM Life accelerates drug development and reduces the need for animal testing by analyzing pharmaceuticals before human trials.

The FDA published two discussion papers this week about areas artificial intelligence and machine learning may improve drug development and manufacturing processes.

The FDA may approve birth control pills over-the-counter by the summer, but expressed hesitation due to concerns over women misreading labels on the drug's health concerns.

Eli Lilly's tirzepatide, which is approved to treat Type 2 diabetes and sold under the brand name Mounjaro, could become the most effective weight loss treatment.

Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.

Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology.

There is a scarcity of a certain albuterol medication product  – and the Food and Drug Administration said Wednesday night that it is "working to address" that.

In Tuesday night's State of the Union Address, President Biden called for a cap on the price of insulin.

FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.

The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.

New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.

West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp.

Low-cost preventative HIV medication may be ready as early as 2026, as British pharmaceutical company GSK strikes a deal allowing developing countries access to generic versions.

Four companies that produce honey-based products marketed for sexual enhancement were warned by the FDA this week about hidden prescription drugs.

Pfizer said it was recalling some blood pressure medication and two generic versions Monday over elevated levels of a cancer-causing impurity.

The Sackler family, which owns Purdue Pharma, is willing to contribute more billions to opioid settlements.